APOGEPHA Arzneimittel GmbH: about us

Founded in 1882 in Dresden, APOGEPHA has more than 140 years of experience in the pharmaceutical industry. The first urological research and product developments date back almost as far. Today, APOGEPHA is one of the leading German companies in the field of urology.

We, i.e., about 140 dedicated employees and co-creators, see ourselves not only as a supplier of pharmaceuticals, but also as your partner in urology.

[Translate to English:] Foto vom APOGEPHA-Firmenstandort in Dresden.

About APOGEPHA

APOGEPHA: your partner in urology

Innovation, quality and reliability: APOGEPHA offers patients and doctors the best possible solutions for treating urological and oncological diseases.

APOGEPHA – it's easy here...

Take a walk through Dresden and find out more about us, our services and our passion for urology.

Our products

APOGEPHA offers a wide range of high-quality prescription and over-the-counter drugs for the treatment of urological diseases.

To our products

Company history

Learn more about the history of APOGEPHA, a traditional pharmaceutical manufacturer that has made pharmaceutical history in Dresden.

To the history

Exhibition "New Beginning"

On 16 August 1990, more than 7 years after its incorporation into the VEB Sächsisches Serumwerk in 1983, APOGEPHA reappeared as an independent company in the commercial register of the city of Dresden. This new beginning ended a period of 60 years during which APOGEPHA had to operate as a parastatal or nationally-owned company.

It follows the collapse of the GDR, the peaceful revolution of 1989 and finally the reunification, and ends with the reprivatisation of APOGEPHA in February 1991, whose 30th anniversary we celebrated in 2021.

All these eras have a lot in common: the "New Beginning" exhibition summarises the history of this new beginning and the development of APOGEPHA since 1990.
Dresden, January 2021

To the virtual exhibition tour

Philosophy

Our values: this is what we stand for

As a family-owned business, APOGEPHA stands for continuous corporate development and sustainability. Responsibility, reliability and quality, as well as trusting cooperation, are what shape our values.

We work together in a performance-oriented environment with commitment and passion. We believe that tradition and innovation go hand in hand, and focus on the well-being of our patients.

The health of our patients and improvement in their quality of life are the key motivating forces of our activity. We consider this our social responsibility. We see ourselves not only as a provider of high-quality medicines and services, but also as a partner to doctors, chemists and patients. The trust they place in us is the basis of this cooperation and commitment alike.

We set high standards for ourselves and our work and for the quality and safety of our products. These are therefore manufactured at production sites in Germany and Europe. Our quality management ensures a high and internationally recognised quality level.

As a specialist in urology, we offer high-quality products and services, as well as a comprehensive range of services in this therapeutic field. Our aim is to make a valuable contribution in the field of urology and to optimise treatment options. The needs of patients are an incentive for us. They are the basis for the further development of our products and services. Here, close cooperation with doctors, chemists and patients is very important to us.

In short: in the field of urology, you can count on us completely.

APOGEPHA Arzneimittel GmbH is fully owned by the Starke family and operates as an economically independent company. The commitment and interests of the owner family guarantee sustainable corporate development – this is important to us.

APOGEPHA International

Here is a compilation of information and material for our international partners.

To the partner portal

Management

Get to know our management

Since 1991, APOGEPHA Arzneimittel GmbH has once again been owned by the Starke family, which is now the third generation of shareholders.

Dr. Dirk Pamperin (centre), Dr. Alexandra Pries and Andreas Ott are jointly responsible for the growth and success of the company.

"With high-quality products and scientific service, we want to make a valuable contribution to health, sustainably and in partnership. Responsibility, customer focus and quality are our success factors as a family business and partner in urology."

Dr. rer. nat. Dirk Pamperin, Chairman of the Management Board

[Translate to English:] Foto von Dr. Dirk Pamperin, Vorsitzender der Geschäftsführung bei APOGEPHA.

"I put people first. Maintaining their health and improving it when they are ill is what drives me."

Dr. vet. med. Alexandra Pries, Managing Director Marketing and Sales

[Translate to English:] Foto von Dr. Alexandra Pries, Geschäftsführerin Marketing und Vertrieb bei APOGEPHA.

"Digitalisation will transform the healthcare sector in the coming years. It has great potential for patients, service providers and top performers. We want to play our part in it."

Andreas Ott, Managing Director Finance and Controlling